Company Filing History:
Years Active: 2019-2021
Title: Innovations in Colonic Health: The Patents of Patrick Laughlin Mclean
Introduction
Patrick Laughlin Mclean is an accomplished inventor based in Raleigh, NC, USA. With a focus on health and pharmaceuticals, he has contributed significantly to innovations that enhance colonic health. Mclean holds a total of two patents, showcasing his commitment to advancing medical formulations.
Latest Patents
Mclean's latest patents revolve around **"Formulations and methods of manufacturing formulations for use in colonic evacuation."** These patents describe a solid dosage formulation designed to improve the efficacy of colonic evacuation. The formulation consists of an intra-granular fraction that includes granules with at least one osmotic evacuant agent, one antacid, and a first pharmaceutically acceptable excipient component. Additionally, the extra-granular fraction comprises organic acids, a non-metallic lubricating element, and a second pharmaceutically acceptable excipient component. This innovative approach aims to provide a more effective solution for patients requiring colonic evacuation.
Career Highlights
Patrick Laughlin Mclean works with Redhill Biopharma Ltd., a company dedicated to developing innovative therapeutics for gastrointestinal and infectious diseases. His work at Redhill Biopharma has allowed him to explore and enhance formulations that contribute significantly to patient care and product effectiveness in the pharmaceutical field.
Collaborations
During his career, Mclean has collaborated with various experts to further his research and innovations. One notable coworker is Reza Fathi, who shares a commitment to advancing formulations for healthcare applications. Their collaboration exemplifies the teamwork and shared vision that drive successful innovations in the pharmaceutical industry.
Conclusion
Patrick Laughlin Mclean’s contributions to colonic health through his patented formulations highlight the importance of innovation in medicine. His dedication to improving patient outcomes and advancing pharmaceutical technologies positions him as a significant figure in the field, inspiring future innovations and collaborations.